Bristol Myers Squibb raises 2025 guidance after strong Q1 earnings, driven by growth portfolio and foreign exchange gains.
US spirits exports hit a record $2.4 billion in 2024, driven by European consumers stockpiling American whiskey ahead of a feared 50% EU tariff, but trade tensions remain.
Merck reports strong first-quarter earnings, but faces challenges from tariffs and patent expirations.
Bristol Myers Squibb raises 2025 guidance after strong Q1 earnings, driven by growth portfolio and foreign exchange gains.
US spirits exports hit a record $2.4 billion in 2024, driven by European consumers stockpiling American whiskey ahead of a feared 50% EU tariff, but trade tensions remain.
Merck reports strong first-quarter earnings, but faces challenges from tariffs and patent expirations.